Malignant Mesothelioma Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent and Other … – Medgadget (blog)


Malignant mesothelioma is a rare type of cancer that is characterised by tumor formation in the mesothelium, a tissue layer that covers the pleural organs such as heart, abdomen, lungs and other organs. The largest risk factor of the disease is exposure to asbestos, a silicate mineral. Some of the major symptoms of the disease include cough, shortness of breath and pain in the chest. The symptoms in malignant mesothelioma could take as long as 30 to 50 years to show. Surgery, chemotherapy and radiotherapy are some of the major options available for the treatment of malignant mesothelioma. The prevalence of the disease is not known; but, it is estimated that malignant mesothelioma accounts for approximately 1% of all cancers globally. According to the cancer research, in the U.K., 48% cases of malignant mesothelioma are of people above the age of 75 years.

Explore Report at:

The therapeutics pipeline for malignant mesothelioma is expected to witness considerable growth in the near future on account of increasing exposure of general population to pollutants such as asbestos as a result of rising level of pollution in the environment, eventually leading to increasing prevalence of the disease. Other factors that are expected to contribute to the growth in the therapeutics pipeline of malignant mesothelioma include poor prognosis of the disease, growing healthcare investment on cancer treatments and rising geriatric population.

Request for Table of Content at:

Some of the major players involved in the development of therapeutics for the treatment of malignant mesothelioma include AstraZeneca plc, Boehringer Ingelheim GmbH, Polaris Pharmaceuticals, Inc., PharmaMar S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Bayer AG, Aduro Biotech, Inc., Calithera Biosciences, Inc., CBT Pharmaceuticals, Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and help them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.


Manager – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)



Let’s block ads! (Why?)

Source link


Please enter your comment!
Please enter your name here